mRNA |
TKI258 |
CCLE |
pan-cancer |
AAC |
0.036 |
0.4 |
mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
I-BET151 |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.4 |
mRNA |
ZSTK474 |
GDSC1000 |
pan-cancer |
AAC |
-0.023 |
0.4 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.4 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.4 |
mRNA |
SCH-79797 |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.4 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.4 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.4 |